Bakakos P, Pickard C, Wong W M, Ayre K R, Madden J, Frew A J, Hodges E, Cawley M I D, Smith J L
Department of University of Medicine, Southampton General Hospital, Southampton, UK.
Clin Exp Immunol. 2002 Aug;129(2):370-8. doi: 10.1046/j.1365-2249.2002.01868.x.
In this study we examined the cytokine production by T cells and TCRVbeta subsets in peripheral blood (PB) and synovial fluid (SF) from six RA patients and PB from 10 normal subjects, using three-colour flow cytometry. In two RA subjects we assessed T cell clonality by RT PCR using TCRBV family-specific primers and analysed the CDR3 (complementarity determining region 3) length by GeneScan analysis. A high percentage of IFN-gamma- and IL-2- producing cells was observed among the PB T cells in both the RA patients and normal controls and among the SF T cells in RA patients. In contrast, the percentage of T cells producing IL-4 and IL-5 was small among PB T cells in both RA patients and normal controls and among SF T cells in RA patients. There was no significant difference in the production of IFN-gamma, IL-2 and IL-5 between the two compartments (PB and SF); however, there were significantly more IL-4-producing cells in SF. Molecular analysis revealed clonal expansions of four TCRBV families in SF of two of the RA patients studied: TCRBV6.7, TCRBV13.1 and TCRBV22 in one and TCRBV6.7, TCRBV21.3 and TCRBV22 in the second. These expansions demonstrated cytokine expression profiles that differed from total CD3+ cells, implying that T cell subsets bearing various TCR-Vbeta families may have the potential to modulate the immune response in RA patients.
在本研究中,我们使用三色流式细胞术检测了6例类风湿关节炎(RA)患者外周血(PB)和滑液(SF)以及10例正常受试者PB中T细胞和TCRVβ亚群产生的细胞因子。在2例RA受试者中,我们使用TCRBV家族特异性引物通过RT-PCR评估T细胞克隆性,并通过基因扫描分析分析互补决定区3(CDR3)长度。在RA患者和正常对照的PB T细胞以及RA患者的SF T细胞中均观察到高比例的产生IFN-γ和IL-2的细胞。相比之下,在RA患者和正常对照的PB T细胞以及RA患者的SF T细胞中,产生IL-4和IL-5的T细胞百分比很小。两个区室(PB和SF)之间IFN-γ、IL-2和IL-5的产生没有显著差异;然而,SF中产生IL-4的细胞明显更多。分子分析显示,在所研究的2例RA患者的SF中,四个TCRBV家族发生了克隆性扩增:其中1例为TCRBV6.7、TCRBV13.1和TCRBV22,另一例为TCRBV6.7、TCRBV21.3和TCRBV22。这些扩增显示出与总CD3+细胞不同的细胞因子表达谱,这意味着携带各种TCR-Vβ家族的T细胞亚群可能具有调节RA患者免疫反应的潜力。